Drug Discovery for Nervous System Disorders (R21)

Application Due Date: 2013-01-07  |  Post Date: 2009-10-02  |  Funding Number: PAR-10-002


    Interested in this funding opportunity? Sign Up for it! CLICK HERE TO SIGNUP -> Expand   

Link to Full Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-10-002.html

Description: Purpose. This funding opportunity announcement (FOA) encourages Exploratory/Developmental (R21) grant applications from applicant organizations directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PAR-10-001 that encourages applications under the Research Project Grant (R01) award mechanism. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.

Expected Number of Awards: Not Available
Estimated Total Program Funding: Not Available
Award Ceiling: 200000
Award Floor: None
Cost Sharing or Matching Requirement: N
CFDA Number: 93.242, 93.273, 93.279, 93.866000000
Funding Instrument Type: G

Eligible Applicants:
State Governments
County Governments
City or Township Governments
Special district Governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally r
Nonprofits having a 501(c)(3) status with the IRS, other tha
Nonprofits that do not have a 501(c)(3) status with the IRS,
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others